Company Profile

Banano Biotechnology Co., Ltd. (hereinafter referred to as “Banano”) was established in 2023 and is a high-tech enterprise centered on the research, development, and industrialization of high-throughput genetic testing technologies. The company has introduced internationally leading third-generation sequencing technology—nanopore sequencing—and has proactively deployed major third-generation sequencing platforms both domestically and internationally. To date, Banano has carried out systematic testing and product development on the one of the most advanced sequencing platform, thereby establishing an efficient, multi-platform nanopore sequencing technology and product development system that provides stable and reliable technical support for scientific research services and clinical translational applications.
  • 2023 Company incorporation
  • 2 Development History

News center

Company news

Industry news

06-162022 Anti-tumor traditional Chinese medicine class 1 new drug is coming, sprint to a 1 billion big variety! The TOP10 ranking is changing, two products have increased by more than 40%!